Endometrial hyperplasia (EH) is the precursor lesion for endometrioid adenocarcinoma of
the endometrium (EC), which represents the most common malignancy of the female …

Objective The aim of this guideline is to aid primary care physicians and gynaecologists in
the initial evaluation of women with suspected endometrial hyperplasia, to recommend the …

Endometrial cancer (EC) in young women of reproductive age is a relatively rare diagnosis.
However, since in the modern era women delay their childbearing for a variety of social …

Background Patients younger than 40 years usually present with early-stage endometrial
cancer with favorable prognosis. However, such patients are usually in their childbearing …

Background Metformin, widely used in the treatment of type 2 diabetes mellitus, reduces the
risk of cancer and relapse after treatment. Fertility-sparing treatment for endometrial cancer …

Endometrial cancer is the most common gynecologic cancer in developed countries.
Approximately 3%–14% of endometrial cancers are diagnosed in young women under 40 …

Objective Oral progestin is an alternative to hysterectomy for women with complex atypical
hyperplasia (CAH) or grade one endometrial cancer (G1EC) who wish fertility preservation …

Objective Reports on the repeated administration of medroxyprogesterone acetate (MPA) for
intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia …

Background The gold standard treatment for early-stage endometrial cancer (EC) is
hysterectomy with bilateral salpingo-oophorectomy (BSO) with lymphadenectomy. In …

Endometrial cancer (EC) is the most common gynecologic malignancy in developed
countries and affects predominantly postmenopausal women. It is estimated, however, that …